The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2, Supplement 2 , Pages S388-S392 , February 2008

6. Secondary immunodeficiencies, including HIV infection

  • Javier Chinen, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Javier Chinen, MD, PhD, Department of Pediatrics, Allergy and Immunology Section, Baylor College of Medicine, Texas Children's Hospital, 1102 Bates St. Houston, TX 77030.
    • ,
  • William T. Shearer, MD, PhD

Received 2 May 2007 ,Revised 4 June 2007 ,Accepted 4 June 2007.

References 

  1. Bonilla FA, Geha RS. Update in primary immunodeficiency diseases. J Allergy Clin Immunol. 2006;117:S435–S441
  2. In:  Stiehm ER,  Ochs HD,  Wilkenstein JA editor. Immunologic disorders in infants and children. 3rd ed.. Philadelphia (PA): Elsevier Saunders; 2004;
  3. In:  Rich RR,  Fleisher TA,  Shearer WT,  Kotzin BL,  Schroeder HW editor. Clinical immunology: principles and practice. 2nd ed.. London: Mosby; 2001;
  4. Tan HP, Smaldone MC, Shapiro R. Immunosuppressive preconditioning or induction regimens, evidence to date. Drugs. 2006;66:1535–1545
  5. Pawelec G, Koch S, Franceschi C, Wikby A. Human immunosenescence: does it have an infectious component?. Ann N Y Acad Sci. 2006;1067:56–65
  6. Cunningham-Rundles , McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immunoresponse. J Allergy Clin Immunol. 2005;115:1119–1128
  7. Douglas SD. Down syndrome: immunologic and epidemiologic associations-enigmas remain. J Pediatr. 2005;147:723–725
  8. Shearer WT, Zhang S, Reuben JM, Lee BM, Butel JS. Effects of radiation and latent virus on immune responses in a space flight model. J Allergy Clin Immunol. 2005;115:1297–1303
  9. Sleasman JW, Goodenow MM. HIV-1 infection. J Allergy Clin Immunol. 2003;111:582–592
  10. UNAIDS. AIDS pandemic update: special report on HIV/AIDS: December 2006. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2006.
  11. Center for Disease Control and Prevention . HIV/AIDS surveillance report. Vol 18. Atlanta (GA): Department of Health and Human Services; 2005;
  12. Goodenow MM, Collman RG. HIV-1 coreceptor is distinct from viral tropism: a dual-parameter nomenclature to define viral phenotypes. J Leukoc Biol. 2006;80:965–972
  13. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 2004;4:868–877
  14. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200:749–759
  15. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP, et al. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses. 2006;22:757–762
  16. Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest. 2006;116:2161–2172
  17. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, Kitahata M, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA. 2006;296:1498–1506
  18. Paul ME, Mao C, Charurat M, Serchuck L, Foca M, Hayani K, et al. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol. 2005;115:848–855
  19. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. October 10, 2006. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentsGL.pdf. Accessed April 30, 2007.
  20. Stoll M, Schmidt RE. Adverse events of desirable gain in immunocompetence: the immune restoration inflammatory syndromes. Autoimmun Rev. 2004;3:243–249
  21. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. October 26, 2006. Available at: http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Accessed April 30, 2007.
  22. McMichael A. HIV vaccines. Annu Rev Immunol. 2006;24:227–255
  23. Lederman MM, Offord RE, Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol. 2006;6:371–382
  24. Cohen J. Hope on new AIDS drugs, but breast-feeding strategy backfires. Science. 2007;315:1357
  25. Newell ML, Barninghausen T. Male circumcision to cut HIV risk in the general population. Lancet. 2007;369:617–618

 Supported by National Institutes of Health grants AI27551, AI36211, AI6944I, HD41983, RR0188, HD79533, HL72705, and HD78522 and the David Fund, the Pediatrics AIDS Fund, and the Immunology Research Fund, Texas Children's Hospital.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01046-9

doi: 10.1016/j.jaci.2007.06.003

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2, Supplement 2 , Pages S388-S392 , February 2008

Article Tools

* Image Usage & Resolution